Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prevalence rate of osteoporosis and it's actual management condition in Prostate cancer patients who takes LHRH antagonist and anti androgen
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To define prevalence rate of osteoporosis in Prostate cancer patients who take LHRH antagonist or anti androgen (include MAB) at the stage of before treatment or it's initial stage. |
| Measure | Description | Time Frame |
|---|---|---|
| To assess whether proper osteoporosis prevention and treatment was given or not according to osteoporosis treatment guideline in prostate cancer patients who are enrolled in this study. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Korean prostate cancer patients who are taking LHRH antagonist or anti- androgen or both of them within 6 months since starting.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joon Woo Bahn, MD | AstraZeneca Korea | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Cheonan-si | Chungcheongnam-do | South Korea | |||
| Research Site |
Not provided
Not provided
Not provided
Not provided
| Gangneung-si |
| Gangwon-do |
| South Korea |
| Research Site | Goyang-si | Gyeonggi-do | South Korea |
| Research Site | Guri-si | Gyeonggi-do | South Korea |
| Research Site | Gumi | Gyeongsangbuk-do | South Korea |
| Research Site | Gyeongju | Gyeongsangbuk-do | South Korea |
| Research Site | Masan-si | Gyeongsangnam-do | South Korea |
| Research Site | Iksan-si | Jeollabuk-do | South Korea |
| Research Site | Cheongju-si | North Chungcheong | South Korea |
| Research Site | Chungju | North Chungcheong | South Korea |
| Research Site | Daegu | South Korea |
| Research Site | Daejeon | South Korea |
| Research Site | Gwangju | South Korea |
| Research Site | Incheon | South Korea |
| Research Site | Jeju City | South Korea |
| Research Site | Pusan | South Korea |
| Research Site | Seoul | South Korea |
| Research Site | Ulsan | South Korea |
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| D010024 | Osteoporosis |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |
| D001851 | Bone Diseases, Metabolic |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided